CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Acer Therapeutics

For profit

Also known as: ACER | Acer Therapeutics Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 30, 2022

First marketed drug

Dec 22, 2022

Last known activity

Dec 31, 2023

Acquired by Zevra Therapeutics on Nov 20, 2023

Timeline

2010s

  1. Jun 1, 2013

    Acer Therapeutics— Founded

  2. Jul 3, 2017

    Opexa Therapeutics— Acquired

2020s

  1. Dec 22, 2022

    sodium phenylbutyrate— Marketing Organization

  2. Dec 22, 2022

    sodium phenylbutyrate— NDA Secondary Org

  3. Nov 20, 2023

    Zevra Therapeutics— Acquired By

Drugs by trial phase (5 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 2 via acquisition)

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Cambridge, MA, US Jun 1, 2013
Last known activity
Dec 31, 2023